5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology


 

Future Directions in Multiple Myeloma: Selinexor Approval, Venetoclax, Belantamab Mafodotin, BCMA:CD3 Bispecifics & CAR T

60 views
March 13, 2020
Comments 0
Login to view comments. Click here to Login